000			01593 a2200469 4500
005			20250516004541.0
264		0	_c20110128
008			201101s 0 0 eng d
022			_a1827-1596
040			_aNLM _beng _cNLM
100	1		_aKampmeier, T G
245	0	0	_aVasopressin in sepsis and septic shock. _h[electronic resource]
260			_bMinerva anestesiologica _cOct 2010
300			_a844-50 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdrenal Cortex Hormones _xadverse effects
650	0	4	_aAnimals
650	0	4	_aArginine Vasopressin _xadministration & dosage
650	0	4	_aCatecholamines _xadverse effects
650	0	4	_aDrug Administration Routes
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aDrug Interactions
650	0	4	_aDrug Therapy, Combination
650	0	4	_aHumans
650	0	4	_aHypotension _xdrug therapy
650	0	4	_aIschemia _xchemically induced
650	0	4	_aLypressin _xadministration & dosage
650	0	4	_aMolecular Structure
650	0	4	_aMulticenter Studies as Topic
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aReceptors, Vasopressin _xagonists
650	0	4	_aSepsis _xcomplications
650	0	4	_aShock, Septic _xcomplications
650	0	4	_aTerlipressin
650	0	4	_aVasoconstriction _xdrug effects
650	0	4	_aVasoconstrictor Agents _xadministration & dosage
700	1		_aRehberg, S
700	1		_aWestphal, M
700	1		_aLange, M
773	0		_tMinerva anestesiologica _gvol. 76 _gno. 10 _gp. 844-50
999			_c20239651 _d20239651